Merck & Co., Inc. (NYSE:MRK) Q4 2025 Earnings Call Transcript February 3, 2026 Merck & Co., Inc. beats earnings expectations.

Lawmakers haven't adjusted per-pupil state funding for public education in 13 years. This year, they could raise it—and tie ...

Dohmen Company Foundation, a private foundation guided by a vision of life without diet-related disease, today announced the release of its 2025 Impact Report, highlighting a year of focused progress, ...

Amgen Inc. ( AMGN) Q4 2025 Earnings Call February 3, 2026 4:30 PM EST ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

The Class 10 CBSE board exams is going to start soon. Students who are going to appear can use the essential study materials ...

The first patient has been dosed in a first-in-human phase 1/2 trial evaluating DS3790 in patients with relapsed or refractory B-cell non-Hodgkin lymphoma. DS3790 is a specifically engineered, ...

Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company focused on delivering a new class of innovative immunotherapies for patients with cancer and other incurable diseases, announced today that a late ...

Amgen Inc. delivered strong operational performance across the board in 2025, and you can see that in the breadth of our business. Three of these, Repatha, Evenity, and TestSpire, all grew by more ...

Eli Lilly delivered a robust 4Q25 beat, with revenue up 43% YoY and strong EPS growth, driven by its GLP-1 franchise. Check out my latest analysis on LLY stock.

Winnie's Hole is a delightfully grim roguelite where you infect and constantly mutate Winnie-the-Pooh. Now available in Early Access.

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Curium Group today announced that together with PeptiDream Inc. and PDRadiopharma Inc., the first patient has been dosed in the companies’ registrational ...